21.99000 USD
0.29
1.30%
Last update Dec 18, 3:59 PM EST
Post-market
Day range
21.81000
22.69500
Previous close
22.28000
Open
22.35000
Access this stock data via API
Subscribe
Arcus Biosciences Inc.
21.99
0.29
1.30%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 258M 117M 112M 383M
Cost of revenue
Gross profit
Operating expense
Research & development 448M 340M 288M 257M
Selling general and admin 120M 117M 104M 72M
Other operating expenses
Operating income -310M -340M -280M 54M
Non operating interest income
Income 52M 41M 16M 1M
Expense 4M 2M 2M 0
Other income expense -20M
Pretax income -283M -301M -266M 55M
Tax provision 1M 6M 1M 2M
Net income -284M -307M -267M 53M
Basic EPS -3.1 -4.2 -3.7 0.8
Diluted EPS -3.1 -4.2 -3.7 0.7
Basic average shares 90.1M 74M 72M 69.3M
Diluted average shares 90.1M 74M 72M 69.3M
EBITDA -249M -291M -258M 59M
Net income from continuing op. -283M -307M -267M 53M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Post-market

Exchange is currently open for post-market.
Post market session closes in 2 hours 37 minutes

17:23
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).